Cytomegalovirus Nosode Liquid
NDC Package 43742-1815-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.
This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Cytomegalovirus Nosode liquids is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a liquid delivery system. Marketed by Deseret Biologicals, Inc., this product is identified by NDC 43742-1815.

Identification & Billing

NDC Package Code
43742-1815-1
Package Description
960 mL in 1 BOTTLE, PLASTIC
Product Code
43742-1815
11-Digit Billing Format
43742181501

Clinical Specifications

Proprietary Name
Cytomegalovirus Nosode
Non-Proprietary Name
Cytomegalovirus Nosode
Substance Name
Human Herpesvirus 5
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s)
HUMAN HERPESVIRUS 5 20 [hp_X]/mL

Regulatory & Marketing

Labeler Name
Deseret Biologicals, Inc.
Product Type
Bulk Ingredient
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
01-07-2021
End Marketing Date
08-10-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43742-1815-1 identifies a specific commercial package of 960 ml in 1 bottle, plastic of Cytomegalovirus Nosode (UNFINISHED drug), a bulk ingredient labeled by Deseret Biologicals, Inc.. This liquid is formulated for use and contains human herpesvirus 5 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Deseret Biologicals, Inc. on January 07, 2021.

How is this Deseret Biologicals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43742181501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
43742-1815-1
11-Digit CMS (5-4-2)
43742-1815-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.